Geneos Wealth Management’s CDK Global, Inc. CDK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-613
| Closed | -$33K | – | 2729 |
|
|
2022
Q2 | $33K | Sell |
613
-31
| -5% | -$1.68K | ﹤0.01% | 1469 |
|
|
2022
Q1 | $31K | Hold |
644
| – | – | ﹤0.01% | 1598 |
|
|
2021
Q4 | $26K | Hold |
644
| – | – | ﹤0.01% | 1756 |
|
|
2021
Q3 | $27K | Hold |
644
| – | – | ﹤0.01% | 1776 |
|
|
2021
Q2 | $32K | Sell |
644
-909
| -59% | -$48.1K | ﹤0.01% | 1695 |
|
|
2021
Q1 | $83K | Hold |
1,553
| – | – | ﹤0.01% | 1385 |
|
|
2020
Q4 | $34K | Buy |
1,553
+1,220
| +366% | +$57.9K | ﹤0.01% | 1656 |
|
|
2020
Q3 | $14K | Hold |
333
| – | – | ﹤0.01% | 1846 |
|
|
2020
Q2 | $13K | Sell |
333
-18
| -5% | -$693 | ﹤0.01% | 1824 |
|
|
2020
Q1 | $11K | Hold |
351
| – | – | ﹤0.01% | 1800 |
|
|
2019
Q4 | $19K | Hold |
351
| – | – | ﹤0.01% | 1718 |
|
|
2019
Q3 | $16K | Sell |
351
-26
| -7% | -$1.25K | ﹤0.01% | 1722 |
|
|
2019
Q2 | $18K | Buy |
377
+22
| +6% | +$1.18K | ﹤0.01% | 1698 |
|
|
2019
Q1 | $20K | Hold |
355
| – | – | ﹤0.01% | 1587 |
|
|
2018
Q4 | $16K | Hold |
355
| – | – | ﹤0.01% | 1615 |
|
|
2018
Q3 | $22K | Sell |
355
-11
| -3% | -$697 | ﹤0.01% | 1542 |
|
|
2018
Q2 | $23K | Hold |
366
| – | – | ﹤0.01% | 1396 |
|
|
2018
Q1 | $23K | Hold |
366
| – | – | ﹤0.01% | 1343 |
|
|
2017
Q4 | $26K | Sell |
366
-64
| -15% | -$4.3K | ﹤0.01% | 1289 |
|
|
2017
Q3 | $27K | Sell |
430
-300
| -41% | -$18.9K | ﹤0.01% | 1215 |
|
|
2017
Q2 | $45K | Sell |
730
-27
| -4% | -$1.69K | ﹤0.01% | 966 |
|
|
2017
Q1 | $49K | Sell |
757
-597
| -44% | -$38.2K | 0.01% | 895 |
|
|
2016
Q4 | $80K | Buy |
1,354
+9
| +0.7% | +$515 | 0.01% | 677 |
|
|
2016
Q3 | $77K | Sell |
1,345
-71
| -5% | -$4.08K | 0.01% | 667 |
|
|
2016
Q2 | $79K | Hold |
1,416
| – | – | 0.01% | 659 |
|
|
2016
Q1 | $65K | Buy |
+1,416
| New | +$63K | 0.01% | 718 |
|
Other funds holding CDK
IA
AWM
BTI
HI
CWC
Geneos Wealth Management's CDK Position: Q3 2022 in Review
Geneos Wealth Management sold out of CDK Global, Inc. (CDK) in Q3 2022, closing a stake of 613 shares — an estimated $33K sold.
Geneos Wealth Management first reported a position in CDK in Q1 2016 and held it in 26 quarters. The position peaked at $83K in Q1 2021. 6 funds tracked by Wall St. Rank hold CDK as of Q3 2022.
- Geneos Wealth Management reported no remaining CDK Global, Inc. position as of Q3 2022 after selling out during the quarter.
- Geneos Wealth Management sold 613 CDK Global, Inc. shares in Q3 2022, an estimated $33K.
- Geneos Wealth Management first reported a position in CDK Global, Inc. in Q1 2016 and held it in 26 quarters.
- Geneos Wealth Management's CDK Global, Inc. position peaked at $83K in Q1 2021.
- 6 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q3 2022.
Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.